Goa, KL; Sorkin, EM. Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy.. Drugs. September 1993, 46 (3): 409–27. PMID 7693432. doi:10.2165/00003495-199346030-00007.
Wijemanne, S; Jankovic, J. Restless legs syndrome: clinical presentation diagnosis and treatment.. Sleep medicine. June 2015, 16 (6): 678–90. PMID 25979181. doi:10.1016/j.sleep.2015.03.002.
Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur. J. Neurol. September 2010, 17 (9): 1113–e88. PMID 20402746. doi:10.1111/j.1468-1331.2010.02999.x.
Gabapentin. International Drug Price Indicator Guide. [13 March 2016].[永久失效連結]
nih.gov
ncbi.nlm.nih.gov
Goa, KL; Sorkin, EM. Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy.. Drugs. September 1993, 46 (3): 409–27. PMID 7693432. doi:10.2165/00003495-199346030-00007.
Wijemanne, S; Jankovic, J. Restless legs syndrome: clinical presentation diagnosis and treatment.. Sleep medicine. June 2015, 16 (6): 678–90. PMID 25979181. doi:10.1016/j.sleep.2015.03.002.
Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur. J. Neurol. September 2010, 17 (9): 1113–e88. PMID 20402746. doi:10.1111/j.1468-1331.2010.02999.x.
Moore, RA; Wiffen, PJ; Derry, S; Toelle, T; Rice, AS. Gabapentin for chronic neuropathic pain and fibromyalgia in adults.. The Cochrane database of systematic reviews. 27 April 2014, 4: CD007938. PMID 24771480.
